Author: Jessica Pasley
Apr. 12, 2018—Every 10 minutes someone is added to the national organ transplant wait list.
Apr. 5, 2018—For the seventh time, VUMC has been named a Leader in LGBTQ Healthcare Equality by the Human Rights Campaign Healthcare Equality Index 2018.
Apr. 5, 2018—Charlotte Haffner, Vanderbilt’s first patient to undergo a heart transplant followed by a stem cell transplant to treat a plasma cell disorder called primary AL amyloidosis, now she dedicates her time to raising awareness about the rare disease.
Apr. 5, 2018—A national effort seeks to raise awareness about an uncommon cause of heart attacks in otherwise healthy, young and middle-aged women.
Mar. 29, 2018—There are no words for liver transplantation in Somalian refugee Aniso Haji’s native language.
Mar. 22, 2018—The rates of myopia, or nearsightedness, in pediatric patients have steadily increased with little to no change in treatment, which, for decades, has had ophthalmologists and optometrists turning to corrective lenses for improved vision.
Mar. 8, 2018—The heart transplant team at Vanderbilt University Medical Center successfully transplanted two hearts using a novel preservation and transport technology allowing the heart to beat outside of the body for an extended amount of time.
Feb. 22, 2018—A team of researchers, led by David Calkins, PhD, vice chair and director of Research at the Vanderbilt Eye Institute, has made a breakthrough discovery in the field of glaucoma showing new hopes for treatments to preserve vision.
Feb. 22, 2018—Paul Sternberg Jr., MD, George Weeks Hale Professor and chair of Ophthalmology and Visual Sciences at Vanderbilt, was recently named president-elect of the Association of University Professors of Ophthalmology (AUPO).
Feb. 22, 2018—Since launching its program offering patients with non-valvular atrial fibrillation (AF) an alternative treatment to reduce their risk of stroke and avoiding long-term use of blood thinners, the Vanderbilt Heart and Vascular Institute (VHVI) has consistently ranked among the top centers in the country for the implantation of left atrial appendage closure (LAAC) devices.